000			01404 a2200361 4500
005			20250515054849.0
264		0	_c20080129
008			200801s 0 0 eng d
022			_a1569-1993
024	7		_a10.1016/j.jcf.2006.12.007 _2doi
040			_aNLM _beng _cNLM
100	1		_aTouw, D J
245	0	0	_aPopulation pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis. _h[electronic resource]
260			_bJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society _cSep 2007
300			_a327-33 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAnti-Bacterial Agents _xadministration & dosage
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCystic Fibrosis _xcomplications
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aModels, Theoretical
650	0	4	_aRetrospective Studies
650	0	4	_aTobramycin _xadministration & dosage
700	1		_aKnox, A J
700	1		_aSmyth, A
773	0		_tJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society _gvol. 6 _gno. 5 _gp. 327-33
856	4	0	_uhttps://doi.org/10.1016/j.jcf.2006.12.007 _zAvailable from publisher's website
999			_c16836826 _d16836826